BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 11746391)

  • 21. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML; Owens T
    Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
    Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
    J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis.
    Elhofy A; Wang J; Tani M; Fife BT; Kennedy KJ; Bennett J; Huang D; Ransohoff RM; Karpus WJ
    J Leukoc Biol; 2005 Feb; 77(2):229-37. PubMed ID: 15539456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse.
    Nygårdas PT; Määttä JA; Hinkkanen AE
    Eur J Immunol; 2000 Jul; 30(7):1911-8. PubMed ID: 10940880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
    Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
    Topham PS; Csizmadia V; Soler D; Hines D; Gerard CJ; Salant DJ; Hancock WW
    J Clin Invest; 1999 Dec; 104(11):1549-57. PubMed ID: 10587518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
    Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
    J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis.
    Jiang Y; Salafranca MN; Adhikari S; Xia Y; Feng L; Sonntag MK; deFiebre CM; Pennell NA; Streit WJ; Harrison JK
    J Neuroimmunol; 1998 Jun; 86(1):1-12. PubMed ID: 9655467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells.
    Sallusto F; Kremmer E; Palermo B; Hoy A; Ponath P; Qin S; Förster R; Lipp M; Lanzavecchia A
    Eur J Immunol; 1999 Jun; 29(6):2037-45. PubMed ID: 10382767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
    Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
    J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
    J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
    Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
    Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of chemokines and chemokine receptors during human renal transplant rejection.
    Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
    Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection.
    Nansen A; Marker O; Bartholdy C; Thomsen AR
    Eur J Immunol; 2000 Jul; 30(7):1797-806. PubMed ID: 10940868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis.
    Reynolds ND; Lukacs NW; Long N; Karpus WJ
    J Immunol; 2011 Sep; 187(5):2803-13. PubMed ID: 21788444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.